NRC Relative Valuation - National Research Corp

Watchlist Manager

Watchlist

Price: 13.87 USD -4.74% Market Closed

Market Cap: $314.3m

Relative Value

The Relative Value of one NRC stock under the Base Case scenario is 20.38 USD. Compared to the current market price of 13.87 USD, National Research Corp is Undervalued by 32%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

NRC Relative Value

Base Case

Undervaluation 32%

Relative Value

Price

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
US		National Research Corp NASDAQ:NRC	312.8m USD	2.4	28.1	13.2	17.6
US		CVS Health Corp NYSE:CVS	97.4B USD	0.2	207.6	13.8	13.8
US	C	Cigna Group XMUN:CGN	65.9B EUR	0.3	12.6	8	10.2
US		Cigna Corp NYSE:CI	78.1B USD	0.3	12.7	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	28.4B EUR	1.3	24.6	10.7	16.3
DE		Fresenius Medical Care AG XMUN:FME	23.7B EUR	1.2	32.9	10.4	22.1
US		Laboratory Corporation of America Holdings NYSE:LH	24B USD	1.7	28.1	15	20.9
US		Quest Diagnostics Inc NYSE:DGX	23B USD	2.2	24.5	13.1	17.7
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.7B EUR	0.6	16.1	6.4	13.7
US		Guardant Health Inc NASDAQ:GH	13.3B USD	14.8	-33.5	-35.3	-32.1
US		DaVita Inc NYSE:DVA	9.9B USD	0.7	13.2	7.1	9.6

				Revenue Growth	P/S to Growth
US		National Research Corp NASDAQ:NRC	Average P/S: 2.3 2.4	N/A	N/A
US		CVS Health Corp NYSE:CVS	0.2	5%	0
US	C	Cigna Group XMUN:CGN	0.3	8%	0
US		Cigna Corp NYSE:CI	0.3	8%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.3	5%	0.3
DE		Fresenius Medical Care AG XMUN:FME	1.2	3%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.7	7%	0.2
US		Quest Diagnostics Inc NYSE:DGX	2.2	7%	0.3
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.6	3%	0.2
US		Guardant Health Inc NASDAQ:GH	14.8	30%	0.5
US		DaVita Inc NYSE:DVA	0.7	4%	0.2

				Earnings Growth	PEG
US		National Research Corp NASDAQ:NRC	Average P/E: 40 28.1	N/A	N/A
US		CVS Health Corp NYSE:CVS	207.6	32%	6.5
US	C	Cigna Group XMUN:CGN	12.6	39%	0.3
US		Cigna Corp NYSE:CI	12.7	39%	0.3
DE		Fresenius SE & Co KGaA XETRA:FRE	24.6	71%	0.3
DE		Fresenius Medical Care AG XMUN:FME	32.9	37%	0.9
US		Laboratory Corporation of America Holdings NYSE:LH	28.1	30%	0.9
US		Quest Diagnostics Inc NYSE:DGX	24.5	14%	1.7
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	16.1	37%	0.4
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -33.5	N/A	N/A
US		DaVita Inc NYSE:DVA	13.2	24%	0.6

				EBITDA Growth	EV/EBITDA to Growth
US		National Research Corp NASDAQ:NRC	Average EV/EBITDA: 10.9 13.2	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.8	25%	0.6
US	C	Cigna Group XMUN:CGN	8	4%	2
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	10.7	14%	0.8
DE		Fresenius Medical Care AG XMUN:FME	10.4	10%	1
US		Laboratory Corporation of America Holdings NYSE:LH	15	16%	0.9
US		Quest Diagnostics Inc NYSE:DGX	13.1	8%	1.6
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	6.4	10%	0.6
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -35.3	N/A	N/A
US		DaVita Inc NYSE:DVA	7.1	5%	1.4

				EBIT Growth	EV/EBIT to Growth
US		National Research Corp NASDAQ:NRC	Average EV/EBIT: 15.8 17.6	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.8	19%	0.7
US	C	Cigna Group XMUN:CGN	10.2	5%	2
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	16.3	20%	0.8
DE		Fresenius Medical Care AG XMUN:FME	22.1	25%	0.9
US		Laboratory Corporation of America Holdings NYSE:LH	20.9	27%	0.8
US		Quest Diagnostics Inc NYSE:DGX	17.7	11%	1.6
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	13.7	25%	0.5
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -32.1	N/A	N/A
US		DaVita Inc NYSE:DVA	9.6	8%	1.2

National Research Corp
NASDAQ:NRC

Relative Value

Valuation Multiples

Multiples Across Competitors

NRC Competitors Multiples
National Research Corp Competitors

See Also

Company

Help

Tools

Stocks

National Research Corp NASDAQ:NRC

Relative Value

Valuation Multiples

Multiples Across Competitors

NRC Competitors Multiples National Research Corp Competitors

See Also

Company

Help

Tools

Stocks

National Research Corp
NASDAQ:NRC

NRC Competitors Multiples
National Research Corp Competitors